AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Apply straightforward methods to follow a new budget, like trigger-based checks and clear spending rules. These strategies boost adherence over time.
24,213 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Tesla is moving past traditional cars with a key AI chip milestone. This article breaks down what the AI5 tape-out me...
As AI data centers push energy use higher, nuclear power is being framed as the only real baseload option. This piece...
Investors cheered a strong tesla quarterly deliveries jump, yet the stock traded lower. This article unpacks the reas...
The head of the Virtual Assets Regulatory Authority warns that the sector’s AI-driven future will advance only as fas...
A wall street insider says SK Hynix's roughly $28 billion IPO could pull capital from AI memory stocks, triggering ra...
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Berkshire Hathaway faces a pivotal July 22 shareholder vote on a major housing bet. This deep dive explains what’s at...
Real Brokerage and REMAX will vote virtually on August 14 to approve a merger that would create the Real REMAX Group....
BlackRock kicked off 2026 with record ETF inflows and a quarterly earnings beat, fueling optimism across markets. The...
NVIDIA unveils a robotics AI model aimed at real-world manipulation tasks, signaling a potential market catalyst for ...
South Korea is accelerating its digital won experiment, moving from a controlled test to a broader rollout. This arti...